NitroMed, Inc. Executive Officer Compensation Disclosure (March 2005)

Contract Categories: Human Resources › Compensation Agreements
Summary

This document outlines the annual salaries, bonuses, and other compensation for the named executive officers of NitroMed, Inc. as of March 10, 2005. It lists the compensation details for six executives, including the President and CEO, Chief Medical Officer, and other senior officers. The document also notes that these executives are eligible to participate in NitroMed's 2003 Amended and Restated Stock Incentive Plan and any future plans. The additional compensation includes payments for group term life insurance premiums.

View More
EX-10.26 8 a2153193zex-10_26.txt EXHIBIT 10.26 Exhibit 10.26 COMPENSATION OF NAMED EXECUTIVE OFFICERS OF NITROMED, INC. As of March 10, 2005, the following sets forth the compensation of the named executive officers (as defined in Item 402(a)(3) of Regulation S-K) of NitroMed, Inc.:
CURRENT ANNUAL OTHER EXECUTIVE OFFICER SALARY 2004 BONUS COMPENSATION(1) Michael D. Loberg, Ph.D. President and Chief Executive Officer $332,470 $116,365 $1,032 Manuel Worcel, M.D. Chief Medical Officer $268,830 $104,844 $3,048 L. Gordon Letts, Ph.D. Chief Scientific Officer and Senior Vice President, Research and Development $248,636 $62,159 $1,025 Lawrence E. Bloch, M.D., J.D. Chief Financial Officer and Chief Business Officer $265,000 $22,083 $72 James G. Ham, III Vice President of Finance $180,000 $12,000 $224 Mark H. Pavao Senior Vice President of Sales and Marketing $250,000 $31,250 $120
(1) Amounts represent the payments of premiums on group term life insurance. In addition, each of NitroMed, Inc.'s named executive officers is eligible to participate in NitroMed's 2003 Amended and Restated Stock Incentive Plan and any successor plan.